fosamprenavir calcium tablet, film coated
mylan pharmaceuticals inc. - fosamprenavir calcium (unii: id1gu2627n) (amprenavir - unii:5s0w860xnr) - fosamprenavir 700 mg - fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection. the following points should be considered when initiating therapy with fosamprenavir plus ritonavir in protease inhibitor-experienced patients: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to fosamprenavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. limited data are available for use of fosamprenavir in pregnancy. fosamprenavir 700 mg twice daily taken with ritonavir 100 mg twice daily should only be considered in pregnant patients who are already on a stable twice-daily regimen of fosamprenavir/ritonavir 700 mg/100 mg prior to pregnancy, and who are virologically suppressed (hiv-1 rna less than 50 copies per ml) (see clinical considerations and data). there are insufficient human data on the use of fosam
telzir suspension
viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - suspension - 50mg - fosamprenavir (fosamprenavir calcium) 50mg - hiv protease inhibitors
telzir 50mgml oral suspension
viiv healthcare uk ltd - fosamprenavir calcium - oral suspension - 50mg/1ml
agenerase
glaxosmithkline nz limited - amprenavir 50mg - soft gelatin capsule - 50 mg - active: amprenavir 50mg excipient: gelatin macrogol 400 propylene glycol tocofersolan
agenerase
glaxosmithkline nz limited - amprenavir 150mg - soft gelatin capsule - 150 mg - active: amprenavir 150mg excipient: gelatin macrogol 400 propylene glycol tocofersolan
telzir fosamprenavir 700mg (as calcium) tablet
viiv healthcare pty ltd - fosamprenavir calcium, quantity: 853.2 mg (equivalent: fosamprenavir, qty 700 mg) - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; triacetin; iron oxide red - telzir, in combination with low dose ritonavir, is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infected adults, adolescents and children of 6 years and above in combination with other antiretroviral medicinal products. in antiretroviral experienced adults telzir in combination with low dose ritonavir has not been shown to be as effective as lopinavir/ritonavir. no comparative studies have been undertaken in children or adolescents.
agenerase capsule
glaxosmithkline inc - amprenavir - capsule - 50mg - amprenavir 50mg - hiv protease inhibitors
agenerase capsule
glaxosmithkline inc - amprenavir - capsule - 150mg - amprenavir 150mg - hiv protease inhibitors
spedra avanafil 50 mg tablet blister pack
a menarini australia pty ltd - avanafil, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; mannitol; fumaric acid; calcium carbonate; hyprolose; iron oxide yellow - treatment of erectile dysfunction in adult males.
telzir tablet
viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - tablet - 700mg - fosamprenavir (fosamprenavir calcium) 700mg - hiv protease inhibitors